Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01080521 · ClinicalTrials.gov registry record
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A clinical trial, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- 247
- Enrollment target
NCT01080521 is a clinical trial that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 247 participants.
The verdict
NCT01080521 has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- 247 participants
- Enrollment target
Study Summary
This clinical trial is studying changes in brain function in patients with stage I, stage II, stage III, or stage IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy. Learning about the effects of chemotherapy on brain function may help doctors plan cancer treatments.
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Cognitive Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2010-04 |
| Est. Completion | 2018-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01080521
The ClinicalTrials.gov registry entry for NCT01080521 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01080521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01080521 about?
NCT01080521 is a clinical study titled "Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy". This clinical trial is studying changes in brain function in patients with stage I, stage II, stage III, or stage IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy. Learning about the effects of chemotherapy on brain function may help doctors plan cancer treatme...
What is the current status of trial NCT01080521?
This trial is currently completed. The enrollment target is 247 participants. The study started on 2010-04. Estimated completion is 2018-01-27.
What interventions are being tested in trial NCT01080521?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Cognitive Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT01080521?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.